BACKGROUND: The consequences of multimorbidity include polypharmacy and repeated referrals for specialised care, which may increase the risk of adverse drug events (ADEs). AIM: The objective of this study was to analyse the influence of multimorbidity, polypharmacy, and multiple referrals on the frequency of ADEs, as an indicator of therapeutic safety, in the context of a national healthcare system. DESIGN AND SETTING: This was a multicentre, retrospective, observational study of 79 089 adult patients treated during 2008 in primary care centres. METHOD: The explanatory patient variables sex, age, level of multimorbidity, polypharmacy, number of primary care physician visits, and number of different specialties attended were analysed. The response variable was the occurrence of ADEs. Logistic regression models were used to identify associations among the analysed variables. RESULTS: The prevalence of individuals with at least one ADE was 0.88%. Multivariate analysis identified the following variables as risk factors for the occurrence of ADE in descending order of effect size: multimorbidity level (odds ratio [OR]Veryhigh/Low = 45.26; ORHigh/Low = 17.58; ORModerate/Low = 4.25), polypharmacy (OR = 1.34), female sex (OR = 1.31), number of different specialties (OR = 1.20), and number of primary care physician visits (OR = 1.01). Age, however, did not show statistical significance (OR = 1.00; 95% confidence interval = 0.996 to 1.005). CONCLUSION: The results of this study demonstrate that multimorbidity is strongly related to the occurrence of ADEs, insofar as it requires the intervention of multiple specialties and the prescription of multiple medications. Further research should shed light on the causal pathway between multimorbidity and increased risk of adverse events.
BACKGROUND: The consequences of multimorbidity include polypharmacy and repeated referrals for specialised care, which may increase the risk of adverse drug events (ADEs). AIM: The objective of this study was to analyse the influence of multimorbidity, polypharmacy, and multiple referrals on the frequency of ADEs, as an indicator of therapeutic safety, in the context of a national healthcare system. DESIGN AND SETTING: This was a multicentre, retrospective, observational study of 79 089 adult patients treated during 2008 in primary care centres. METHOD: The explanatory patient variables sex, age, level of multimorbidity, polypharmacy, number of primary care physician visits, and number of different specialties attended were analysed. The response variable was the occurrence of ADEs. Logistic regression models were used to identify associations among the analysed variables. RESULTS: The prevalence of individuals with at least one ADE was 0.88%. Multivariate analysis identified the following variables as risk factors for the occurrence of ADE in descending order of effect size: multimorbidity level (odds ratio [OR]Veryhigh/Low = 45.26; ORHigh/Low = 17.58; ORModerate/Low = 4.25), polypharmacy (OR = 1.34), female sex (OR = 1.31), number of different specialties (OR = 1.20), and number of primary care physician visits (OR = 1.01). Age, however, did not show statistical significance (OR = 1.00; 95% confidence interval = 0.996 to 1.005). CONCLUSION: The results of this study demonstrate that multimorbidity is strongly related to the occurrence of ADEs, insofar as it requires the intervention of multiple specialties and the prescription of multiple medications. Further research should shed light on the causal pathway between multimorbidity and increased risk of adverse events.
Authors: Terry S Field; Jerry H Gurwitz; Leslie R Harrold; Jeffrey Rothschild; Kristin R DeBellis; Andrew C Seger; Jill C Auger; Leslie A Garber; Cynthia Cadoret; Leslie S Fish; Lawrence D Garber; Michael Kelleher; David W Bates Journal: J Am Geriatr Soc Date: 2004-08 Impact factor: 5.562
Authors: Kenneth E Schmader; Joseph T Hanlon; Carl F Pieper; Richard Sloane; Christine M Ruby; Jack Twersky; Susan Dove Francis; Laurence G Branch; Catherine I Lindblad; Margaret Artz; Morris Weinberger; John R Feussner; Harvey Jay Cohen Journal: Am J Med Date: 2004-03-15 Impact factor: 4.965
Authors: Barbara Starfield; Klaus W Lemke; Terence Bernhardt; Steven S Foldes; Christopher B Forrest; Jonathan P Weiner Journal: Ann Fam Med Date: 2003 May-Jun Impact factor: 5.166
Authors: Alexandra Prados-Torres; Beatriz Poblador-Plou; Amaia Calderón-Larrañaga; Luis Andrés Gimeno-Feliu; Francisca González-Rubio; Antonio Poncel-Falcó; Antoni Sicras-Mainar; José Tomás Alcalá-Nalvaiz Journal: PLoS One Date: 2012-02-29 Impact factor: 3.240
Authors: Hélène Carrier; Anna Zaytseva; Aurélie Bocquier; Patrick Villani; Hélène Verdoux; Martin Fortin; Pierre Verger Journal: Br J Gen Pract Date: 2019-02-25 Impact factor: 5.386
Authors: Elaine K Walsh; Laura J Sahm; Colin P Bradley; Kieran Dalton; Kathleen O'Sullivan; Stephen McCarthy; Eimear Connolly; Ciara Fitzgerald; William H Smithson; David Kerins; Derina Byrne; Patricia M Kearney Journal: Br J Gen Pract Date: 2019-05 Impact factor: 5.386
Authors: Terri R Fried; John O'Leary; Virginia Towle; Mary K Goldstein; Mark Trentalange; Deanna K Martin Journal: J Am Geriatr Soc Date: 2014-12 Impact factor: 5.562
Authors: Matthew F Griffith; Laura C Feemster; Steven B Zeliadt; Lucas M Donovan; Laura J Spece; Edmunds M Udris; David H Au Journal: J Gen Intern Med Date: 2019-11-11 Impact factor: 5.128
Authors: Elisa Fabbri; Marco Zoli; Marta Gonzalez-Freire; Marcel E Salive; Stephanie A Studenski; Luigi Ferrucci Journal: J Am Med Dir Assoc Date: 2015-05-07 Impact factor: 4.669